(Q44796576)

6 December 2017

Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir (English)

1 reference

6 December 2017

1 reference

Scott M Palmer

1

1 reference

6 December 2017

Dan C Grinnan

2

1 reference

6 December 2017

B Diane Reams

3

1 reference

6 December 2017

Mark P Steele

4

1 reference

6 December 2017

Robert H Messier

5

1 reference

6 December 2017

R Duane Davis

6

1 reference

6 December 2017

1 April 2004

1 reference

6 December 2017

Clinical Transplantation

1 reference

6 December 2017

18

1 reference

6 December 2017

2

1 reference

6 December 2017

179-185

1 reference

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

6 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

Pharmacokinetic assessment of oral ganciclovir in lung transplant recipients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

Risk factors for bronchiolitis obliterans: a systematic review of recent publications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0012.2003.00152.X

10.1046/J.1399-0012.2003.00152.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference